Intawat Nookaew
Concepts (663)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| High-Throughput Nucleotide Sequencing | 11 | 2024 | 182 | 2.800 |
Why?
| | Saccharomyces cerevisiae | 19 | 2021 | 176 | 2.750 |
Why?
| | Software | 11 | 2024 | 280 | 2.050 |
Why?
| | Genomics | 14 | 2023 | 268 | 1.950 |
Why?
| | Genome, Fungal | 10 | 2020 | 29 | 1.800 |
Why?
| | Phylogeny | 11 | 2023 | 231 | 1.740 |
Why?
| | Metagenome | 9 | 2024 | 40 | 1.720 |
Why?
| | Genome | 6 | 2022 | 62 | 1.690 |
Why?
| | Bacteria | 14 | 2025 | 228 | 1.590 |
Why?
| | Gene Expression Profiling | 28 | 2024 | 1105 | 1.550 |
Why?
| | Transcriptome | 19 | 2024 | 370 | 1.510 |
Why?
| | Genome, Viral | 6 | 2020 | 83 | 1.500 |
Why?
| | Metabolic Networks and Pathways | 14 | 2021 | 93 | 1.410 |
Why?
| | Osteocytes | 5 | 2024 | 226 | 1.350 |
Why?
| | Computational Biology | 9 | 2024 | 212 | 1.330 |
Why?
| | Sequence Analysis, DNA | 9 | 2024 | 229 | 1.290 |
Why?
| | Models, Biological | 15 | 2020 | 735 | 1.270 |
Why?
| | Metagenomics | 6 | 2024 | 46 | 1.200 |
Why?
| | Nanopores | 3 | 2022 | 3 | 1.090 |
Why?
| | Systems Biology | 8 | 2016 | 33 | 1.080 |
Why?
| | DNA, Circular | 2 | 2022 | 18 | 1.000 |
Why?
| | Osteoblasts | 4 | 2025 | 475 | 0.990 |
Why?
| | Sequence Analysis, RNA | 8 | 2022 | 100 | 0.970 |
Why?
| | Gastrointestinal Tract | 10 | 2020 | 108 | 0.910 |
Why?
| | Mice | 36 | 2025 | 5949 | 0.900 |
Why?
| | DNA Adducts | 2 | 2025 | 79 | 0.900 |
Why?
| | Animals | 51 | 2025 | 13505 | 0.890 |
Why?
| | Periosteum | 1 | 2024 | 26 | 0.870 |
Why?
| | Genetic Variation | 6 | 2020 | 230 | 0.870 |
Why?
| | Databases, Genetic | 9 | 2020 | 83 | 0.850 |
Why?
| | Mitochondria | 5 | 2025 | 430 | 0.800 |
Why?
| | Genome, Bacterial | 12 | 2020 | 58 | 0.790 |
Why?
| | Lipid Metabolism | 7 | 2019 | 187 | 0.770 |
Why?
| | RNA, Fungal | 2 | 2021 | 19 | 0.760 |
Why?
| | Virulence | 3 | 2020 | 167 | 0.740 |
Why?
| | Streptococcus suis | 1 | 2020 | 1 | 0.710 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2021 | 24 | 0.710 |
Why?
| | Drug Resistance, Microbial | 1 | 2020 | 47 | 0.700 |
Why?
| | Geography | 1 | 2020 | 65 | 0.700 |
Why?
| | Signal Transduction | 13 | 2024 | 1671 | 0.680 |
Why?
| | Oligonucleotide Array Sequence Analysis | 11 | 2018 | 405 | 0.670 |
Why?
| | Herpesviridae | 1 | 2020 | 19 | 0.670 |
Why?
| | Helicobacter pylori | 3 | 2017 | 65 | 0.670 |
Why?
| | Energy Metabolism | 5 | 2023 | 302 | 0.650 |
Why?
| | DNA, Viral | 1 | 2020 | 137 | 0.640 |
Why?
| | Metabolome | 8 | 2019 | 101 | 0.630 |
Why?
| | Bone and Bones | 6 | 2025 | 494 | 0.590 |
Why?
| | Diet | 6 | 2019 | 587 | 0.570 |
Why?
| | Escherichia coli Proteins | 3 | 2025 | 55 | 0.570 |
Why?
| | Saccharomyces cerevisiae Proteins | 5 | 2015 | 139 | 0.570 |
Why?
| | Single-Cell Analysis | 3 | 2024 | 81 | 0.560 |
Why?
| | Humans | 66 | 2025 | 52483 | 0.560 |
Why?
| | Eicosapentaenoic Acid | 4 | 2019 | 24 | 0.550 |
Why?
| | Docosahexaenoic Acids | 4 | 2019 | 31 | 0.550 |
Why?
| | Diet, High-Fat | 7 | 2019 | 236 | 0.550 |
Why?
| | Viruses | 1 | 2017 | 25 | 0.530 |
Why?
| | Penaeidae | 3 | 2021 | 4 | 0.520 |
Why?
| | Head and Neck Neoplasms | 1 | 2019 | 288 | 0.510 |
Why?
| | Mice, Inbred C57BL | 16 | 2025 | 1884 | 0.510 |
Why?
| | Proteomics | 3 | 2018 | 329 | 0.500 |
Why?
| | Bone Density | 4 | 2025 | 399 | 0.490 |
Why?
| | Fishes | 3 | 2013 | 25 | 0.470 |
Why?
| | Gastritis, Atrophic | 2 | 2017 | 5 | 0.470 |
Why?
| | Gastric Mucosa | 2 | 2017 | 45 | 0.450 |
Why?
| | RNA, Messenger | 9 | 2022 | 1132 | 0.450 |
Why?
| | Adipose Tissue | 2 | 2013 | 204 | 0.440 |
Why?
| | Fatty Acids, Unsaturated | 4 | 2020 | 39 | 0.440 |
Why?
| | Aspergillus oryzae | 4 | 2017 | 23 | 0.440 |
Why?
| | Purpura, Thrombocytopenic, Idiopathic | 4 | 2016 | 24 | 0.430 |
Why?
| | Escherichia coli | 3 | 2025 | 192 | 0.410 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2019 | 133 | 0.410 |
Why?
| | Proteome | 5 | 2019 | 171 | 0.400 |
Why?
| | Basal Metabolism | 1 | 2012 | 33 | 0.400 |
Why?
| | Transcription, Genetic | 3 | 2021 | 378 | 0.400 |
Why?
| | Spleen | 3 | 2019 | 172 | 0.390 |
Why?
| | Male | 35 | 2025 | 26761 | 0.390 |
Why?
| | Metabolomics | 4 | 2021 | 150 | 0.390 |
Why?
| | Adjuvants, Immunologic | 3 | 2019 | 52 | 0.380 |
Why?
| | Intestinal Mucosa | 4 | 2025 | 224 | 0.380 |
Why?
| | Osteolysis | 2 | 2022 | 75 | 0.370 |
Why?
| | Hepatitis C | 2 | 2023 | 79 | 0.370 |
Why?
| | Multiple Myeloma | 5 | 2024 | 3049 | 0.370 |
Why?
| | Germinal Center | 2 | 2025 | 30 | 0.360 |
Why?
| | DNA | 4 | 2025 | 549 | 0.360 |
Why?
| | Chlorobi | 1 | 2011 | 2 | 0.360 |
Why?
| | Bacteroidetes | 1 | 2011 | 4 | 0.360 |
Why?
| | Lipids | 4 | 2019 | 155 | 0.360 |
Why?
| | Bone Diseases, Metabolic | 2 | 2022 | 78 | 0.360 |
Why?
| | RNA, Ribosomal, 16S | 7 | 2024 | 118 | 0.360 |
Why?
| | Glioma | 2 | 2023 | 78 | 0.360 |
Why?
| | Enterotoxigenic Escherichia coli | 2 | 2022 | 4 | 0.350 |
Why?
| | Biology | 1 | 2010 | 8 | 0.350 |
Why?
| | Meiosis | 2 | 2021 | 74 | 0.350 |
Why?
| | Sterols | 1 | 2010 | 8 | 0.350 |
Why?
| | Reproducibility of Results | 11 | 2020 | 1229 | 0.340 |
Why?
| | Bone Resorption | 2 | 2023 | 302 | 0.340 |
Why?
| | Gene Expression Regulation | 15 | 2020 | 990 | 0.340 |
Why?
| | Female | 32 | 2025 | 28171 | 0.340 |
Why?
| | Gene Regulatory Networks | 4 | 2021 | 111 | 0.340 |
Why?
| | T-Lymphocytes | 5 | 2023 | 340 | 0.330 |
Why?
| | Cytokines | 5 | 2023 | 623 | 0.320 |
Why?
| | Mice, Knockout | 5 | 2025 | 879 | 0.320 |
Why?
| | Phospholipids | 3 | 2021 | 59 | 0.320 |
Why?
| | RNA Interference | 2 | 2019 | 181 | 0.310 |
Why?
| | Carcinoma, Hepatocellular | 2 | 2022 | 202 | 0.310 |
Why?
| | RNA | 4 | 2022 | 168 | 0.310 |
Why?
| | Aged | 15 | 2024 | 10121 | 0.300 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2019 | 93 | 0.300 |
Why?
| | HIV Infections | 2 | 2023 | 389 | 0.290 |
Why?
| | Brain Neoplasms | 2 | 2023 | 291 | 0.290 |
Why?
| | Tumor Microenvironment | 3 | 2024 | 256 | 0.290 |
Why?
| | Cell Differentiation | 6 | 2022 | 665 | 0.290 |
Why?
| | Bifidobacterium | 2 | 2020 | 5 | 0.290 |
Why?
| | Liver Neoplasms | 2 | 2022 | 333 | 0.290 |
Why?
| | Algorithms | 4 | 2024 | 672 | 0.290 |
Why?
| | Microcephaly | 2 | 2018 | 41 | 0.280 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2021 | 44 | 0.280 |
Why?
| | Proteins | 1 | 2010 | 348 | 0.280 |
Why?
| | MicroRNAs | 3 | 2019 | 387 | 0.280 |
Why?
| | Plant Extracts | 2 | 2020 | 194 | 0.270 |
Why?
| | NAD | 2 | 2025 | 45 | 0.270 |
Why?
| | Internet | 5 | 2017 | 263 | 0.270 |
Why?
| | Osteoclasts | 4 | 2024 | 428 | 0.270 |
Why?
| | Cell Proliferation | 3 | 2025 | 1023 | 0.270 |
Why?
| | Feces | 4 | 2020 | 153 | 0.260 |
Why?
| | Osteogenesis | 4 | 2025 | 366 | 0.260 |
Why?
| | Immune System | 3 | 2016 | 42 | 0.250 |
Why?
| | Polymerase Chain Reaction | 4 | 2021 | 461 | 0.250 |
Why?
| | Malates | 3 | 2017 | 7 | 0.250 |
Why?
| | Neutrophils | 2 | 2019 | 147 | 0.250 |
Why?
| | Populus | 2 | 2015 | 8 | 0.250 |
Why?
| | Middle Aged | 13 | 2021 | 13028 | 0.250 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2020 | 505 | 0.250 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2025 | 20 | 0.240 |
Why?
| | Dietary Fiber | 1 | 2025 | 24 | 0.240 |
Why?
| | Arachidonic Acid | 3 | 2020 | 34 | 0.240 |
Why?
| | Recombination, Genetic | 3 | 2021 | 109 | 0.240 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2018 | 560 | 0.240 |
Why?
| | Mutation | 4 | 2025 | 1347 | 0.230 |
Why?
| | Plasmids | 3 | 2020 | 163 | 0.230 |
Why?
| | Hemiptera | 2 | 2021 | 7 | 0.230 |
Why?
| | Herpesvirus 4, Human | 1 | 2025 | 43 | 0.230 |
Why?
| | Rhadinovirus | 1 | 2025 | 22 | 0.230 |
Why?
| | Virus Latency | 1 | 2025 | 53 | 0.230 |
Why?
| | Cell Division | 1 | 2025 | 291 | 0.230 |
Why?
| | Chromosome Mapping | 3 | 2017 | 154 | 0.230 |
Why?
| | Chemokine CXCL12 | 1 | 2024 | 32 | 0.220 |
Why?
| | Isocitrate Dehydrogenase | 2 | 2023 | 20 | 0.220 |
Why?
| | Biomass | 3 | 2015 | 21 | 0.220 |
Why?
| | Homeodomain Proteins | 2 | 2022 | 80 | 0.220 |
Why?
| | Leukocytes, Mononuclear | 2 | 2022 | 123 | 0.220 |
Why?
| | Aquaculture | 2 | 2021 | 4 | 0.220 |
Why?
| | Carcinoma, Renal Cell | 2 | 2016 | 111 | 0.220 |
Why?
| | Chondrocytes | 1 | 2024 | 41 | 0.220 |
Why?
| | Adipose Tissue, White | 3 | 2019 | 35 | 0.220 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2024 | 857 | 0.220 |
Why?
| | Thailand | 2 | 2020 | 6 | 0.220 |
Why?
| | B-Lymphocytes | 1 | 2025 | 184 | 0.210 |
Why?
| | Antiviral Agents | 2 | 2023 | 178 | 0.210 |
Why?
| | Bacteriological Techniques | 2 | 2020 | 42 | 0.210 |
Why?
| | Autophagy | 1 | 2025 | 193 | 0.210 |
Why?
| | Oligodendroglioma | 1 | 2023 | 6 | 0.210 |
Why?
| | Inflammation | 6 | 2023 | 641 | 0.210 |
Why?
| | Organ Specificity | 2 | 2016 | 115 | 0.210 |
Why?
| | Transcription Factors | 9 | 2023 | 566 | 0.210 |
Why?
| | Astrocytoma | 1 | 2023 | 19 | 0.210 |
Why?
| | Adenine | 2 | 2021 | 31 | 0.210 |
Why?
| | Genome Size | 3 | 2020 | 7 | 0.210 |
Why?
| | Cell Line | 3 | 2021 | 1030 | 0.210 |
Why?
| | Cell Line, Tumor | 6 | 2024 | 1470 | 0.210 |
Why?
| | Rhamnaceae | 1 | 2023 | 1 | 0.210 |
Why?
| | Reactive Oxygen Species | 1 | 2025 | 421 | 0.210 |
Why?
| | Genome, Chloroplast | 1 | 2023 | 2 | 0.210 |
Why?
| | Molecular Sequence Data | 5 | 2018 | 778 | 0.200 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2025 | 221 | 0.200 |
Why?
| | Staphylococcus aureus | 3 | 2021 | 338 | 0.200 |
Why?
| | Eukaryotic Cells | 1 | 2022 | 15 | 0.200 |
Why?
| | Pilot Projects | 3 | 2020 | 721 | 0.200 |
Why?
| | Microbial Sensitivity Tests | 2 | 2020 | 284 | 0.200 |
Why?
| | Oxidative Phosphorylation | 2 | 2020 | 46 | 0.200 |
Why?
| | Base Sequence | 4 | 2021 | 640 | 0.200 |
Why?
| | Pichia | 2 | 2012 | 8 | 0.200 |
Why?
| | Bone Neoplasms | 1 | 2024 | 184 | 0.200 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2022 | 10 | 0.200 |
Why?
| | Hepatitis C, Chronic | 1 | 2023 | 86 | 0.200 |
Why?
| | Escherichia coli Infections | 1 | 2022 | 29 | 0.200 |
Why?
| | Cyclic AMP | 1 | 2022 | 91 | 0.200 |
Why?
| | Estrogens | 2 | 2022 | 223 | 0.190 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2024 | 326 | 0.190 |
Why?
| | Gene Expression Regulation, Bacterial | 2 | 2025 | 187 | 0.190 |
Why?
| | Data Interpretation, Statistical | 2 | 2013 | 164 | 0.190 |
Why?
| | Spermatozoa | 1 | 2021 | 25 | 0.190 |
Why?
| | Chemotaxis | 2 | 2019 | 21 | 0.190 |
Why?
| | Principal Component Analysis | 4 | 2016 | 53 | 0.190 |
Why?
| | Phenotype | 5 | 2023 | 789 | 0.190 |
Why?
| | Chromosomes, Human | 1 | 2021 | 41 | 0.190 |
Why?
| | Quinoxalines | 1 | 2021 | 26 | 0.190 |
Why?
| | Cell Communication | 1 | 2022 | 71 | 0.190 |
Why?
| | Benzofurans | 1 | 2021 | 18 | 0.190 |
Why?
| | Case-Control Studies | 8 | 2018 | 1201 | 0.180 |
Why?
| | Neck Pain | 1 | 2021 | 10 | 0.180 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 44 | 0.180 |
Why?
| | Adenosine Triphosphate | 2 | 2020 | 205 | 0.180 |
Why?
| | Back Pain | 1 | 2021 | 39 | 0.180 |
Why?
| | Templates, Genetic | 1 | 2021 | 13 | 0.180 |
Why?
| | User-Computer Interface | 3 | 2017 | 79 | 0.180 |
Why?
| | Coinfection | 1 | 2021 | 47 | 0.180 |
Why?
| | Triglycerides | 2 | 2019 | 165 | 0.180 |
Why?
| | RNA, Ribosomal | 1 | 2021 | 18 | 0.180 |
Why?
| | Arthralgia | 1 | 2021 | 44 | 0.180 |
Why?
| | Imidoesters | 1 | 2020 | 1 | 0.180 |
Why?
| | Netherlands | 1 | 2020 | 16 | 0.180 |
Why?
| | Swine Diseases | 1 | 2020 | 7 | 0.180 |
Why?
| | Methyltransferases | 1 | 2021 | 29 | 0.180 |
Why?
| | Professional-Patient Relations | 1 | 2021 | 47 | 0.180 |
Why?
| | Nucleotide Motifs | 1 | 2021 | 23 | 0.180 |
Why?
| | RNA, Bacterial | 1 | 2021 | 57 | 0.180 |
Why?
| | Imidazoles | 1 | 2021 | 124 | 0.170 |
Why?
| | Canada | 1 | 2020 | 104 | 0.170 |
Why?
| | Lactobacillus plantarum | 1 | 2020 | 1 | 0.170 |
Why?
| | Surface Properties | 1 | 2020 | 62 | 0.170 |
Why?
| | Monocyte-Macrophage Precursor Cells | 1 | 2020 | 7 | 0.170 |
Why?
| | Stereoisomerism | 1 | 2020 | 101 | 0.170 |
Why?
| | Adult | 11 | 2022 | 14161 | 0.170 |
Why?
| | Host-Pathogen Interactions | 2 | 2019 | 144 | 0.170 |
Why?
| | China | 1 | 2020 | 134 | 0.170 |
Why?
| | Particle Size | 1 | 2020 | 82 | 0.170 |
Why?
| | DNA Modification Methylases | 1 | 2020 | 28 | 0.170 |
Why?
| | Muscle, Skeletal | 3 | 2016 | 804 | 0.170 |
Why?
| | Mortierella | 1 | 2020 | 1 | 0.170 |
Why?
| | Acetyl Coenzyme A | 1 | 2020 | 5 | 0.170 |
Why?
| | DNA Repair Enzymes | 1 | 2020 | 43 | 0.170 |
Why?
| | ROC Curve | 1 | 2021 | 253 | 0.170 |
Why?
| | Streptococcal Infections | 1 | 2020 | 49 | 0.170 |
Why?
| | Cell Culture Techniques | 1 | 2020 | 102 | 0.160 |
Why?
| | Alum Compounds | 1 | 2019 | 3 | 0.160 |
Why?
| | Helicobacter Infections | 2 | 2017 | 63 | 0.160 |
Why?
| | Genome-Wide Association Study | 1 | 2020 | 186 | 0.160 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2023 | 187 | 0.160 |
Why?
| | Molecular Structure | 1 | 2020 | 314 | 0.160 |
Why?
| | Colitis | 1 | 2020 | 51 | 0.160 |
Why?
| | Tumor Suppressor Proteins | 1 | 2020 | 130 | 0.160 |
Why?
| | Mumps virus | 1 | 2019 | 10 | 0.160 |
Why?
| | Neoplasms | 2 | 2025 | 1325 | 0.160 |
Why?
| | Mumps | 1 | 2019 | 13 | 0.160 |
Why?
| | Cannabidiol | 1 | 2020 | 43 | 0.160 |
Why?
| | Computer Simulation | 5 | 2013 | 290 | 0.160 |
Why?
| | Swine | 1 | 2020 | 428 | 0.160 |
Why?
| | Cytoskeleton | 1 | 2019 | 39 | 0.160 |
Why?
| | Databases, Protein | 3 | 2015 | 28 | 0.160 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2020 | 164 | 0.160 |
Why?
| | Glycocholic Acid | 1 | 2019 | 1 | 0.160 |
Why?
| | Stress, Mechanical | 1 | 2019 | 92 | 0.160 |
Why?
| | Cholagogues and Choleretics | 1 | 2019 | 5 | 0.160 |
Why?
| | Tea | 1 | 2019 | 17 | 0.160 |
Why?
| | Anti-Obesity Agents | 1 | 2019 | 17 | 0.160 |
Why?
| | Ion Channels | 1 | 2019 | 70 | 0.160 |
Why?
| | Preservation, Biological | 1 | 2018 | 9 | 0.150 |
Why?
| | Microbial Viability | 2 | 2017 | 32 | 0.150 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 2019 | 339 | 0.150 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 128 | 0.150 |
Why?
| | Cell Death | 1 | 2019 | 177 | 0.150 |
Why?
| | Disease Models, Animal | 6 | 2023 | 1478 | 0.150 |
Why?
| | Chronic Pain | 1 | 2021 | 177 | 0.150 |
Why?
| | Disease Outbreaks | 1 | 2019 | 123 | 0.150 |
Why?
| | Sensitivity and Specificity | 2 | 2020 | 891 | 0.150 |
Why?
| | Liver | 5 | 2019 | 1156 | 0.150 |
Why?
| | Molecular Sequence Annotation | 4 | 2020 | 28 | 0.150 |
Why?
| | Prediabetic State | 1 | 2018 | 22 | 0.150 |
Why?
| | 5' Untranslated Regions | 1 | 2018 | 30 | 0.150 |
Why?
| | Cecum | 1 | 2018 | 61 | 0.150 |
Why?
| | Bacterial Physiological Phenomena | 2 | 2020 | 6 | 0.150 |
Why?
| | Cell Movement | 1 | 2019 | 268 | 0.150 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2018 | 90 | 0.150 |
Why?
| | 3' Untranslated Regions | 1 | 2018 | 55 | 0.140 |
Why?
| | Obesity | 3 | 2016 | 1162 | 0.140 |
Why?
| | Duodenum | 1 | 2017 | 34 | 0.140 |
Why?
| | Cell Adhesion | 2 | 2015 | 163 | 0.140 |
Why?
| | Cannabis | 1 | 2020 | 150 | 0.140 |
Why?
| | Neural Stem Cells | 1 | 2017 | 26 | 0.140 |
Why?
| | Epithelial Cells | 2 | 2019 | 215 | 0.140 |
Why?
| | Calcium | 2 | 2016 | 376 | 0.140 |
Why?
| | Gene Expression | 3 | 2019 | 618 | 0.140 |
Why?
| | Tandem Repeat Sequences | 1 | 2017 | 7 | 0.140 |
Why?
| | Eukaryota | 1 | 2017 | 10 | 0.140 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2018 | 81 | 0.140 |
Why?
| | Lipid A | 1 | 2016 | 4 | 0.140 |
Why?
| | Oligodeoxyribonucleotides | 1 | 2016 | 30 | 0.130 |
Why?
| | Colitis, Ulcerative | 1 | 2017 | 67 | 0.130 |
Why?
| | Sequence Alignment | 1 | 2017 | 125 | 0.130 |
Why?
| | Glucosides | 1 | 2016 | 23 | 0.130 |
Why?
| | Stomach | 1 | 2017 | 82 | 0.130 |
Why?
| | Fungal Proteins | 3 | 2017 | 117 | 0.130 |
Why?
| | Genes, Fungal | 2 | 2013 | 31 | 0.130 |
Why?
| | Protein Biosynthesis | 1 | 2019 | 258 | 0.130 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2016 | 43 | 0.130 |
Why?
| | Autoimmunity | 2 | 2016 | 34 | 0.130 |
Why?
| | Muscle Relaxation | 1 | 2016 | 15 | 0.130 |
Why?
| | Protein Conformation | 1 | 2017 | 176 | 0.130 |
Why?
| | Immunization | 2 | 2019 | 69 | 0.130 |
Why?
| | Glycosaminoglycans | 1 | 2016 | 19 | 0.130 |
Why?
| | Meat | 2 | 2013 | 60 | 0.130 |
Why?
| | Nitrogen | 2 | 2013 | 70 | 0.130 |
Why?
| | Microwaves | 2 | 2013 | 11 | 0.130 |
Why?
| | Aging | 1 | 2021 | 701 | 0.130 |
Why?
| | DNA, Bacterial | 2 | 2020 | 176 | 0.130 |
Why?
| | Oligopeptides | 1 | 2016 | 92 | 0.130 |
Why?
| | Adhesins, Bacterial | 1 | 2016 | 28 | 0.130 |
Why?
| | Inositol | 2 | 2013 | 19 | 0.130 |
Why?
| | Pseudomonas | 1 | 2015 | 5 | 0.120 |
Why?
| | Running | 1 | 2016 | 22 | 0.120 |
Why?
| | Coronary Artery Disease | 1 | 2019 | 294 | 0.120 |
Why?
| | Melanoma, Experimental | 1 | 2016 | 40 | 0.120 |
Why?
| | Mice, Transgenic | 3 | 2023 | 552 | 0.120 |
Why?
| | Aorta, Thoracic | 1 | 2016 | 97 | 0.120 |
Why?
| | Ebolavirus | 1 | 2015 | 6 | 0.120 |
Why?
| | Analgesics, Opioid | 1 | 2021 | 590 | 0.120 |
Why?
| | Breast Neoplasms | 1 | 2024 | 1212 | 0.120 |
Why?
| | Cluster Analysis | 5 | 2014 | 233 | 0.120 |
Why?
| | Flocculation | 1 | 2015 | 1 | 0.120 |
Why?
| | Metabolic Engineering | 2 | 2014 | 5 | 0.120 |
Why?
| | Conjugation, Genetic | 1 | 2015 | 2 | 0.120 |
Why?
| | Mannose-Binding Lectins | 1 | 2015 | 8 | 0.120 |
Why?
| | Comparative Genomic Hybridization | 2 | 2015 | 39 | 0.120 |
Why?
| | Muscle Cells | 1 | 2015 | 22 | 0.120 |
Why?
| | Killer Cells, Natural | 1 | 2016 | 116 | 0.120 |
Why?
| | Adipocytes | 2 | 2013 | 132 | 0.120 |
Why?
| | Plant Proteins | 1 | 2015 | 71 | 0.120 |
Why?
| | Fatty Acids | 2 | 2013 | 149 | 0.120 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2014 | 4 | 0.120 |
Why?
| | Bacterial Load | 1 | 2014 | 13 | 0.120 |
Why?
| | Interleukin-6 | 1 | 2016 | 278 | 0.110 |
Why?
| | Kidney Neoplasms | 1 | 2016 | 182 | 0.110 |
Why?
| | Fermentation | 3 | 2025 | 14 | 0.110 |
Why?
| | Database Management Systems | 1 | 2014 | 28 | 0.110 |
Why?
| | Gene Expression Regulation, Fungal | 2 | 2013 | 51 | 0.110 |
Why?
| | Blood Glucose | 2 | 2016 | 473 | 0.110 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2014 | 19 | 0.110 |
Why?
| | Stomach Neoplasms | 1 | 2017 | 194 | 0.110 |
Why?
| | Kidney Failure, Chronic | 1 | 2016 | 210 | 0.110 |
Why?
| | Myocardial Infarction | 1 | 2018 | 412 | 0.110 |
Why?
| | Fatty Liver | 1 | 2015 | 142 | 0.110 |
Why?
| | Loss of Heterozygosity | 1 | 2014 | 78 | 0.110 |
Why?
| | Osteoporosis | 2 | 2025 | 162 | 0.110 |
Why?
| | Models, Theoretical | 2 | 2013 | 185 | 0.110 |
Why?
| | DNA Methylation | 1 | 2018 | 592 | 0.110 |
Why?
| | Cells, Cultured | 3 | 2025 | 1567 | 0.100 |
Why?
| | Penicillium chrysogenum | 1 | 2013 | 1 | 0.100 |
Why?
| | Health | 1 | 2013 | 21 | 0.100 |
Why?
| | Glucose Intolerance | 1 | 2013 | 27 | 0.100 |
Why?
| | Fungi | 1 | 2013 | 51 | 0.100 |
Why?
| | Genes | 1 | 2013 | 31 | 0.100 |
Why?
| | Blood Vessels | 1 | 2013 | 71 | 0.100 |
Why?
| | Carbon Isotopes | 4 | 2014 | 70 | 0.100 |
Why?
| | United States | 2 | 2021 | 5192 | 0.100 |
Why?
| | Adipocytes, Brown | 1 | 2012 | 9 | 0.100 |
Why?
| | Open Reading Frames | 2 | 2013 | 55 | 0.100 |
Why?
| | INDEL Mutation | 1 | 2012 | 4 | 0.100 |
Why?
| | Biosynthetic Pathways | 3 | 2020 | 6 | 0.100 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2012 | 9 | 0.100 |
Why?
| | Industrial Microbiology | 1 | 2012 | 2 | 0.100 |
Why?
| | Multiple Sclerosis | 1 | 2013 | 72 | 0.100 |
Why?
| | Methyl Ethers | 1 | 2012 | 18 | 0.100 |
Why?
| | Aldehyde-Lyases | 1 | 2012 | 1 | 0.100 |
Why?
| | Aspergillus nidulans | 1 | 2012 | 4 | 0.100 |
Why?
| | Leukocytes | 1 | 2012 | 66 | 0.100 |
Why?
| | Choline | 1 | 2012 | 64 | 0.100 |
Why?
| | Cell Lineage | 2 | 2025 | 85 | 0.090 |
Why?
| | Hepacivirus | 2 | 2023 | 106 | 0.090 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2011 | 34 | 0.090 |
Why?
| | Yeasts | 1 | 2011 | 9 | 0.090 |
Why?
| | Staphylococcal Infections | 1 | 2014 | 285 | 0.090 |
Why?
| | Sex Characteristics | 1 | 2012 | 198 | 0.090 |
Why?
| | Insulin Resistance | 1 | 2013 | 275 | 0.090 |
Why?
| | Amino Acid Sequence | 3 | 2018 | 578 | 0.090 |
Why?
| | Vagina | 1 | 2011 | 46 | 0.090 |
Why?
| | Gene Deletion | 2 | 2010 | 272 | 0.090 |
Why?
| | Phosphoglycerate Mutase | 1 | 2010 | 1 | 0.090 |
Why?
| | Adipocytes, White | 1 | 2010 | 3 | 0.090 |
Why?
| | Bone Marrow | 1 | 2012 | 364 | 0.090 |
Why?
| | Aspergillus niger | 1 | 2010 | 6 | 0.080 |
Why?
| | Homeostasis | 2 | 2023 | 201 | 0.080 |
Why?
| | Peptidoglycan | 2 | 2025 | 16 | 0.080 |
Why?
| | Time Factors | 4 | 2019 | 2968 | 0.080 |
Why?
| | RANK Ligand | 2 | 2022 | 187 | 0.080 |
Why?
| | Genotype | 2 | 2023 | 566 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2021 | 137 | 0.080 |
Why?
| | Atherosclerosis | 1 | 2012 | 219 | 0.080 |
Why?
| | Microarray Analysis | 3 | 2015 | 71 | 0.080 |
Why?
| | Drug Combinations | 2 | 2021 | 132 | 0.080 |
Why?
| | Immunity, Innate | 2 | 2020 | 117 | 0.080 |
Why?
| | RNA, Transfer | 1 | 2008 | 13 | 0.070 |
Why?
| | Pregnancy | 4 | 2018 | 2680 | 0.070 |
Why?
| | Corn Oil | 2 | 2019 | 12 | 0.070 |
Why?
| | Gas Chromatography-Mass Spectrometry | 3 | 2013 | 69 | 0.070 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2013 | 185 | 0.070 |
Why?
| | Antigens, Bacterial | 2 | 2019 | 54 | 0.070 |
Why?
| | Energy Transfer | 1 | 2007 | 2 | 0.070 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 240 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2012 | 1678 | 0.070 |
Why?
| | Multilocus Sequence Typing | 2 | 2018 | 7 | 0.070 |
Why?
| | Young Adult | 4 | 2020 | 4329 | 0.070 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2018 | 140 | 0.070 |
Why?
| | Lymphocyte Activation | 2 | 2020 | 172 | 0.070 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2019 | 29 | 0.070 |
Why?
| | Codon | 2 | 2017 | 43 | 0.070 |
Why?
| | Infant | 3 | 2020 | 3733 | 0.060 |
Why?
| | Aged, 80 and over | 1 | 2013 | 3392 | 0.060 |
Why?
| | Bayes Theorem | 2 | 2017 | 121 | 0.060 |
Why?
| | Fatty Acids, Volatile | 1 | 2025 | 14 | 0.060 |
Why?
| | Organ Size | 2 | 2016 | 228 | 0.060 |
Why?
| | Tandem Mass Spectrometry | 2 | 2018 | 251 | 0.060 |
Why?
| | Superoxide Dismutase | 1 | 2025 | 119 | 0.060 |
Why?
| | Cell Wall | 1 | 2025 | 59 | 0.060 |
Why?
| | Child | 4 | 2022 | 7248 | 0.060 |
Why?
| | Lysosomes | 1 | 2025 | 76 | 0.060 |
Why?
| | Femur | 1 | 2025 | 135 | 0.060 |
Why?
| | Tumor Virus Infections | 1 | 2025 | 48 | 0.060 |
Why?
| | NF-kappa B | 2 | 2017 | 322 | 0.060 |
Why?
| | Herpesviridae Infections | 1 | 2025 | 57 | 0.060 |
Why?
| | Arkansas | 2 | 2021 | 2028 | 0.060 |
Why?
| | Interleukin-18 | 1 | 2024 | 27 | 0.050 |
Why?
| | Coenzyme A-Transferases | 1 | 2023 | 1 | 0.050 |
Why?
| | Myeloid Progenitor Cells | 1 | 2023 | 17 | 0.050 |
Why?
| | Chromosomes, Human, Pair 19 | 1 | 2023 | 8 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2018 | 1563 | 0.050 |
Why?
| | Osteoprotegerin | 1 | 2023 | 53 | 0.050 |
Why?
| | Eating | 1 | 2024 | 159 | 0.050 |
Why?
| | Chloroplasts | 1 | 2023 | 4 | 0.050 |
Why?
| | Bacterial Proteins | 2 | 2018 | 361 | 0.050 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2023 | 11 | 0.050 |
Why?
| | Cattle | 2 | 2013 | 205 | 0.050 |
Why?
| | DNA Damage | 1 | 2025 | 305 | 0.050 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2023 | 96 | 0.050 |
Why?
| | Absorptiometry, Photon | 2 | 2013 | 162 | 0.050 |
Why?
| | TNF Receptor-Associated Factor 3 | 1 | 2022 | 13 | 0.050 |
Why?
| | Cystatin M | 1 | 2022 | 19 | 0.050 |
Why?
| | Fucose | 1 | 2022 | 1 | 0.050 |
Why?
| | Putrescine | 1 | 2022 | 4 | 0.050 |
Why?
| | Culture Media | 2 | 2013 | 98 | 0.050 |
Why?
| | Carbon | 2 | 2013 | 55 | 0.050 |
Why?
| | Genome, Human | 2 | 2013 | 121 | 0.050 |
Why?
| | Neurotransmitter Agents | 1 | 2022 | 34 | 0.050 |
Why?
| | Glycolysis | 2 | 2013 | 73 | 0.050 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2022 | 48 | 0.050 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2022 | 50 | 0.050 |
Why?
| | Amino Acids, Essential | 1 | 2024 | 133 | 0.050 |
Why?
| | Prognosis | 2 | 2021 | 2099 | 0.050 |
Why?
| | Ovariectomy | 1 | 2022 | 113 | 0.050 |
Why?
| | Alu Elements | 1 | 2021 | 7 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2020 | 2867 | 0.050 |
Why?
| | Oxidation-Reduction | 1 | 2023 | 326 | 0.050 |
Why?
| | Tryptophan | 1 | 2022 | 89 | 0.050 |
Why?
| | Genes, Essential | 1 | 2021 | 11 | 0.050 |
Why?
| | Mutagenesis, Insertional | 1 | 2021 | 24 | 0.050 |
Why?
| | Gene Library | 1 | 2021 | 44 | 0.050 |
Why?
| | Suramin | 1 | 2021 | 10 | 0.050 |
Why?
| | Apoptosis | 2 | 2020 | 1119 | 0.050 |
Why?
| | Viral Load | 1 | 2021 | 82 | 0.050 |
Why?
| | Sulfoxides | 1 | 2021 | 21 | 0.050 |
Why?
| | Iron | 1 | 2022 | 127 | 0.050 |
Why?
| | DNA Transposable Elements | 1 | 2021 | 107 | 0.050 |
Why?
| | Isothiocyanates | 1 | 2021 | 20 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2021 | 93 | 0.050 |
Why?
| | Chromosomes | 1 | 2021 | 30 | 0.040 |
Why?
| | Rats | 2 | 2018 | 3220 | 0.040 |
Why?
| | Enterococcus | 1 | 2020 | 9 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2023 | 747 | 0.040 |
Why?
| | Clostridium | 1 | 2020 | 17 | 0.040 |
Why?
| | Amino Acids | 2 | 2013 | 377 | 0.040 |
Why?
| | Adolescent | 3 | 2017 | 6739 | 0.040 |
Why?
| | Food Safety | 1 | 2020 | 3 | 0.040 |
Why?
| | Drug Prescriptions | 1 | 2021 | 102 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2023 | 335 | 0.040 |
Why?
| | Alcohol Oxidoreductases | 1 | 2020 | 13 | 0.040 |
Why?
| | Mucin-2 | 1 | 2020 | 8 | 0.040 |
Why?
| | gamma-Linolenic Acid | 1 | 2020 | 1 | 0.040 |
Why?
| | Cohort Studies | 2 | 2016 | 1542 | 0.040 |
Why?
| | Fatty Acid Desaturases | 1 | 2020 | 9 | 0.040 |
Why?
| | Mucorales | 1 | 2020 | 12 | 0.040 |
Why?
| | Disease-Free Survival | 1 | 2021 | 460 | 0.040 |
Why?
| | Cell Count | 1 | 2020 | 149 | 0.040 |
Why?
| | Methylation | 1 | 2020 | 126 | 0.040 |
Why?
| | Dietary Supplements | 1 | 2024 | 465 | 0.040 |
Why?
| | Dydrogesterone | 1 | 2019 | 1 | 0.040 |
Why?
| | Chemokines | 1 | 2020 | 79 | 0.040 |
Why?
| | Workflow | 1 | 2020 | 51 | 0.040 |
Why?
| | Tuberculosis Vaccines | 1 | 2019 | 2 | 0.040 |
Why?
| | Disease Resistance | 1 | 2019 | 9 | 0.040 |
Why?
| | Lentivirus | 1 | 2019 | 17 | 0.040 |
Why?
| | Transduction, Genetic | 1 | 2019 | 44 | 0.040 |
Why?
| | Transgenes | 1 | 2019 | 51 | 0.040 |
Why?
| | Colon | 1 | 2020 | 104 | 0.040 |
Why?
| | Indoles | 1 | 2022 | 278 | 0.040 |
Why?
| | Mumps Vaccine | 1 | 2019 | 5 | 0.040 |
Why?
| | Ovary | 1 | 2020 | 107 | 0.040 |
Why?
| | Child, Preschool | 2 | 2020 | 4076 | 0.040 |
Why?
| | Neutralization Tests | 1 | 2019 | 27 | 0.040 |
Why?
| | Lipid Peroxidation | 1 | 2019 | 97 | 0.040 |
Why?
| | Nanofibers | 1 | 2019 | 8 | 0.040 |
Why?
| | Focal Adhesions | 1 | 2019 | 16 | 0.040 |
Why?
| | Gene Expression Regulation, Plant | 1 | 2019 | 50 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2019 | 95 | 0.040 |
Why?
| | PPAR alpha | 1 | 2019 | 59 | 0.040 |
Why?
| | Mice, Inbred Strains | 1 | 2019 | 163 | 0.040 |
Why?
| | Actin Cytoskeleton | 1 | 2019 | 22 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 108 | 0.040 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 52 | 0.040 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2019 | 64 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2019 | 128 | 0.040 |
Why?
| | Cellular Microenvironment | 1 | 2019 | 30 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2019 | 229 | 0.040 |
Why?
| | Caco-2 Cells | 1 | 2019 | 31 | 0.040 |
Why?
| | Bacterial Adhesion | 1 | 2019 | 16 | 0.040 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2023 | 649 | 0.040 |
Why?
| | Thinness | 1 | 2019 | 44 | 0.040 |
Why?
| | Lung | 1 | 2023 | 509 | 0.040 |
Why?
| | Antibodies, Neutralizing | 1 | 2019 | 78 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2019 | 109 | 0.040 |
Why?
| | Extracellular Matrix | 1 | 2019 | 112 | 0.040 |
Why?
| | Specimen Handling | 1 | 2018 | 56 | 0.040 |
Why?
| | Bacteroides | 1 | 2018 | 14 | 0.040 |
Why?
| | Medicaid | 1 | 2021 | 264 | 0.040 |
Why?
| | Pregnancy Trimester, First | 1 | 2018 | 23 | 0.040 |
Why?
| | Survival Rate | 1 | 2021 | 945 | 0.040 |
Why?
| | Cell Nucleus | 1 | 2019 | 187 | 0.040 |
Why?
| | Mass Spectrometry | 1 | 2019 | 292 | 0.040 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2019 | 184 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2020 | 192 | 0.040 |
Why?
| | Biopsy | 1 | 2020 | 605 | 0.040 |
Why?
| | Africa | 1 | 2017 | 12 | 0.040 |
Why?
| | Asia | 1 | 2017 | 20 | 0.040 |
Why?
| | Superoxides | 1 | 2018 | 46 | 0.040 |
Why?
| | Brazil | 1 | 2017 | 38 | 0.040 |
Why?
| | Selection, Genetic | 1 | 2017 | 28 | 0.040 |
Why?
| | RNA Stability | 1 | 2017 | 25 | 0.040 |
Why?
| | Gene Dosage | 1 | 2018 | 78 | 0.040 |
Why?
| | Physicians | 1 | 2021 | 241 | 0.040 |
Why?
| | Synteny | 1 | 2017 | 7 | 0.040 |
Why?
| | Temperature | 1 | 2018 | 183 | 0.040 |
Why?
| | Bacterial Toxins | 1 | 2018 | 51 | 0.040 |
Why?
| | Clostridium thermocellum | 1 | 2017 | 3 | 0.040 |
Why?
| | Neurogenesis | 1 | 2017 | 27 | 0.040 |
Why?
| | Comorbidity | 1 | 2019 | 625 | 0.040 |
Why?
| | Computer Graphics | 1 | 2017 | 9 | 0.030 |
Why?
| | Clostridium Infections | 1 | 2018 | 55 | 0.030 |
Why?
| | Erythropoiesis | 1 | 2017 | 18 | 0.030 |
Why?
| | Leukotrienes | 1 | 2017 | 9 | 0.030 |
Why?
| | Prostaglandins | 1 | 2017 | 19 | 0.030 |
Why?
| | Systems Analysis | 1 | 2016 | 8 | 0.030 |
Why?
| | Adaptation, Physiological | 1 | 2017 | 110 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 422 | 0.030 |
Why?
| | Aorta | 1 | 2018 | 165 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2016 | 34 | 0.030 |
Why?
| | Hematopoiesis | 1 | 2017 | 69 | 0.030 |
Why?
| | Phosphorylation | 1 | 2017 | 528 | 0.030 |
Why?
| | Nicaragua | 1 | 2016 | 2 | 0.030 |
Why?
| | Mitochondria, Muscle | 1 | 2016 | 40 | 0.030 |
Why?
| | Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2016 | 3 | 0.030 |
Why?
| | Remission, Spontaneous | 1 | 2016 | 24 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2016 | 87 | 0.030 |
Why?
| | Pseudomonas fluorescens | 1 | 2015 | 3 | 0.030 |
Why?
| | Pseudomonas putida | 1 | 2015 | 3 | 0.030 |
Why?
| | Fasting | 1 | 2016 | 75 | 0.030 |
Why?
| | RNA, Plant | 1 | 2015 | 6 | 0.030 |
Why?
| | Rhizosphere | 1 | 2015 | 5 | 0.030 |
Why?
| | Staining and Labeling | 1 | 2016 | 97 | 0.030 |
Why?
| | Diploidy | 1 | 2015 | 25 | 0.030 |
Why?
| | Sequence Analysis, Protein | 1 | 2015 | 19 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 63 | 0.030 |
Why?
| | Plant Roots | 1 | 2015 | 30 | 0.030 |
Why?
| | Panicum | 1 | 2015 | 1 | 0.030 |
Why?
| | Cellulase | 1 | 2015 | 2 | 0.030 |
Why?
| | Filoviridae | 1 | 2015 | 4 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2015 | 82 | 0.030 |
Why?
| | Tumor Burden | 1 | 2016 | 136 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 1378 | 0.030 |
Why?
| | Epinephrine | 1 | 2016 | 97 | 0.030 |
Why?
| | Cations, Divalent | 1 | 2015 | 6 | 0.030 |
Why?
| | Plants | 1 | 2015 | 30 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2016 | 243 | 0.030 |
Why?
| | Pseudomonas aeruginosa | 1 | 2015 | 78 | 0.030 |
Why?
| | Virulence Factors | 1 | 2016 | 80 | 0.030 |
Why?
| | Thioglycolates | 1 | 2014 | 3 | 0.030 |
Why?
| | Cathepsin D | 1 | 2014 | 4 | 0.030 |
Why?
| | Blotting, Western | 1 | 2016 | 590 | 0.030 |
Why?
| | Polysaccharides | 1 | 2015 | 57 | 0.030 |
Why?
| | Genome, Archaeal | 1 | 2014 | 2 | 0.030 |
Why?
| | Disease Progression | 1 | 2017 | 871 | 0.030 |
Why?
| | Vaccination | 1 | 2016 | 298 | 0.030 |
Why?
| | Risk Assessment | 1 | 2019 | 1327 | 0.030 |
Why?
| | Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2014 | 8 | 0.030 |
Why?
| | STAT1 Transcription Factor | 1 | 2014 | 27 | 0.030 |
Why?
| | Butyrates | 1 | 2014 | 30 | 0.030 |
Why?
| | Hardness | 1 | 2013 | 1 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2014 | 190 | 0.030 |
Why?
| | Models, Molecular | 1 | 2015 | 348 | 0.030 |
Why?
| | Adiposity | 1 | 2015 | 143 | 0.030 |
Why?
| | Weaning | 1 | 2013 | 30 | 0.030 |
Why?
| | Weight Gain | 1 | 2015 | 240 | 0.030 |
Why?
| | Esters | 1 | 2013 | 19 | 0.030 |
Why?
| | Tumor Necrosis Factor Ligand Superfamily Member 14 | 1 | 2013 | 2 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2014 | 192 | 0.030 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2013 | 2 | 0.030 |
Why?
| | Isotope Labeling | 1 | 2014 | 57 | 0.030 |
Why?
| | Sweden | 1 | 2013 | 10 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2014 | 117 | 0.030 |
Why?
| | Cell Size | 1 | 2013 | 45 | 0.030 |
Why?
| | Ergosterol | 1 | 2013 | 10 | 0.030 |
Why?
| | Bioengineering | 1 | 2013 | 3 | 0.030 |
Why?
| | NADP | 1 | 2013 | 22 | 0.030 |
Why?
| | Cell Separation | 1 | 2013 | 83 | 0.030 |
Why?
| | Protein Binding | 1 | 2015 | 667 | 0.030 |
Why?
| | Macrophages | 1 | 2016 | 379 | 0.030 |
Why?
| | Tibia | 1 | 2013 | 113 | 0.030 |
Why?
| | G(M2) Ganglioside | 1 | 2013 | 1 | 0.030 |
Why?
| | Keratan Sulfate | 1 | 2013 | 1 | 0.030 |
Why?
| | Androsterone | 1 | 2013 | 2 | 0.030 |
Why?
| | Penicillins | 1 | 2013 | 28 | 0.030 |
Why?
| | Heparitin Sulfate | 1 | 2013 | 9 | 0.030 |
Why?
| | Classification | 1 | 2013 | 12 | 0.030 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2013 | 139 | 0.030 |
Why?
| | Demography | 1 | 2013 | 90 | 0.030 |
Why?
| | Species Specificity | 1 | 2013 | 192 | 0.030 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2012 | 13 | 0.030 |
Why?
| | Carbon Cycle | 1 | 2012 | 6 | 0.030 |
Why?
| | Environment | 1 | 2013 | 89 | 0.030 |
Why?
| | Milk | 1 | 2013 | 81 | 0.030 |
Why?
| | Aerosols | 1 | 2013 | 75 | 0.020 |
Why?
| | Complement Activation | 1 | 2012 | 24 | 0.020 |
Why?
| | Lumbar Vertebrae | 1 | 2013 | 104 | 0.020 |
Why?
| | Esterification | 1 | 2012 | 6 | 0.020 |
Why?
| | Genetic Markers | 1 | 2012 | 109 | 0.020 |
Why?
| | Xylose | 1 | 2012 | 4 | 0.020 |
Why?
| | Leptin | 1 | 2013 | 148 | 0.020 |
Why?
| | Bioreactors | 1 | 2012 | 10 | 0.020 |
Why?
| | Eubacterium | 1 | 2012 | 1 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 673 | 0.020 |
Why?
| | beta Carotene | 1 | 2012 | 9 | 0.020 |
Why?
| | Actinobacteria | 1 | 2012 | 10 | 0.020 |
Why?
| | Oxidoreductases | 1 | 2012 | 59 | 0.020 |
Why?
| | Sepsis | 1 | 2014 | 239 | 0.020 |
Why?
| | Immunity, Cellular | 1 | 2011 | 64 | 0.020 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2013 | 85 | 0.020 |
Why?
| | Administration, Intravaginal | 1 | 2011 | 7 | 0.020 |
Why?
| | Biological Phenomena | 1 | 2011 | 2 | 0.020 |
Why?
| | Body Weight | 1 | 2013 | 523 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2021 | 5422 | 0.020 |
Why?
| | Body Composition | 1 | 2013 | 338 | 0.020 |
Why?
| | Chronic Disease | 1 | 2013 | 586 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2010 | 46 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2012 | 483 | 0.020 |
Why?
| | Models, Animal | 1 | 2011 | 234 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2010 | 37 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2013 | 979 | 0.020 |
Why?
| | Age Factors | 1 | 2013 | 1132 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 706 | 0.020 |
Why?
| | Body Mass Index | 1 | 2013 | 689 | 0.020 |
Why?
| | Oxygen | 1 | 2012 | 336 | 0.020 |
Why?
| | Binding Sites | 1 | 2010 | 377 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2021 | 6607 | 0.020 |
Why?
| | Glucose | 1 | 2010 | 355 | 0.020 |
Why?
| | Ethanol | 1 | 2010 | 342 | 0.020 |
Why?
|
|
Nookaew's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|